作者
Mariann Harangi, Hossein Z Mirdamadi, Ildikó Seres, Ferenc Sztanek, Miklós Molnár, Andrea Kassai, Zoltán Derdák, László Illyés, György Paragh
发表日期
2009/4/1
期刊
Translational Research
卷号
153
期号
4
页码范围
190-198
出版商
Mosby
简介
Human serum paraoxonase-1 (PON1) protects lipoproteins against oxidation by hydrolyzing lipid peroxides in oxidized low-density lipoprotein (LDL); therefore, it may protect against atherosclerosis. Changes in the ratio of high-density lipoprotein (HDL) subfractions may alter the stability and the antioxidant capacity of PON1. The aim of the study was to examine the effect of atorvastatin treatment on the distribution of HDL subfractions, LDL size, cholesteryl ester transfer protein (CETP), lecithin-cholesterol acyltransferase (LCAT), and PON1 activity. In all, 33 patients with type IIa and IIb hypercholesterolemia were involved in the study. LDL sizes and HDL subfractions were determined by gradient gel electrophoresis. CETP, LCAT, and PON1 activities were measured spectrophotometrically. Three months of treatment with atorvastatin 20 mg daily significantly increased the HDL3 (+8.13%) and decreased the HDL2a …
引用总数
2009201020112012201320142015201620172018201920202021202220232024427553436212132